Skip to Content

INVO Bioscience Inc INVO

Morningstar Rating
$1.21 +0.06 (5.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INVO is trading within a range we consider fairly valued.
Price
$1.20
Fair Value
$4.52
Uncertainty
Extreme
1-Star Price
$11.15
5-Star Price
$3.15
Economic Moat
Lfmx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INVO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.15
Day Range
$1.161.22
52-Week Range
$0.5016.40
Bid/Ask
$1.17 / $1.25
Market Cap
$3.02 Mil
Volume/Avg
26,099 / 61,761

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.59
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

INVO Bioscience Inc operates as a medical device company focused on the Assisted Reproductive Technology (ART) marketplace that is creating simplified, lower-cost treatments for patients diagnosed with infertility. The company has developed the INVOcell device and procedure, the first Intravaginal Culture (IVC) system granted FDA clearance in the United States used for the incubation of eggs and sperm during fertilization and early embryo development. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
16

Valuation

Metric
INVO
Price/Earnings (Normalized)
Price/Book Value
8.03
Price/Sales
0.59
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
INVO
Quick Ratio
0.24
Current Ratio
0.37
Interest Coverage
−10.00
Quick Ratio
INVO

Profitability

Metric
INVO
Return on Assets (Normalized)
−91.63%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−167.45%
Return on Assets
INVO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesSfjgkm$205.8 Bil
SYK
Stryker CorpXrf$134.3 Bil
MDT
Medtronic PLCZycff$111.0 Bil
BSX
Boston Scientific CorpQhvjnzp$98.5 Bil
EW
Edwards Lifesciences CorpPwjbyt$51.2 Bil
DXCM
DexCom IncXxy$46.9 Bil
ZBH
Zimmer Biomet Holdings IncLnnpn$25.4 Bil
ALGN
Align Technology IncCsqyxh$23.0 Bil
PHG
Koninklijke Philips NV ADRVrtqww$18.4 Bil
PODD
Insulet CorpVfmzx$11.8 Bil

Sponsor Center